{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:41:50Z","timestamp":1788907310418,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T00:00:00Z","timestamp":1471478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T00:00:00Z","timestamp":1471478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The epidermis is a dynamic tissue in which keratinocytes proliferate in the basal layer and undergo a tightly controlled differentiation while moving into the suprabasal layers. The balance between keratinocyte proliferation, differentiation, and death is essential, and its perturbation can result in pathological changes. Some common skin diseases, such as psoriasis, are characterized by hyperproliferation accompanied by inflammatory reactions, suggesting that molecules with topical anti-inflammatory and ROS scavenging abilities may be useful for their treatment. Here we investigate the potential of the flavone Luteolin-7-glucoside (LUT-7G) as a treatment for psoriasis. We show that LUT-7G leads to a modification of the cell cycle and the induction of keratinocyte differentiation, with modification of energy, fatty acid, and redox metabolism. LUT-7G treatment also neutralizes the proliferative stimulus induced by the proinflammatory cytokines IL-22 and IL-6 in HEKn. Moreover, in the Imiquimod (IMQ) mouse model of psoriasis, topical administration of LUT-7G leads to a marked reduction of acanthosis and re-expression of epidermal differentiation markers. Dissection of the IL-22 signalling pathway, activated by IMQ treatment, demonstrates that LUT-7G impairs the nuclear translocation of phosphorylated (activated) STAT3, blocking the IL-22 signalling cascade. Thus LUT-7G appears to be a promising compound for the treatment of hyperproliferative and inflammatory skin diseases, such as psoriasis.<\/jats:p>","DOI":"10.1038\/cddis.2016.201","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T12:48:54Z","timestamp":1471524534000},"page":"e2344-e2344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Luteolin-7-glucoside inhibits IL-22\/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model"],"prefix":"10.1038","volume":"7","author":[{"given":"R","family":"Palombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Savini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Avigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Albanesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7351-5676","authenticated-orcid":false,"given":"A","family":"Mauriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Melino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-2252","authenticated-orcid":false,"given":"A","family":"Terrinoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,18]]},"reference":[{"key":"BFcddis2016201_CR1","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1152\/physrev.1989.69.4.1316","volume":"69","author":"RL Eckert","year":"1989","unstructured":"Eckert RL . Structure, function, and differentiation of the keratinocyte. Physiol Rev 1989; 69: 1316\u20131346.","journal-title":"Physiol Rev"},{"key":"BFcddis2016201_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1083\/jcb.200708185","volume":"180","author":"E Fuchs","year":"2008","unstructured":"Fuchs E . Skin stem cells: rising to the surface. J Cell Biol 2008; 180: 273\u2013284.","journal-title":"J Cell Biol"},{"key":"BFcddis2016201_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-3-540-69185-3_9","volume":"24","author":"G Melino","year":"1998","unstructured":"Melino G, De Laurenzi V, Catani MV, Terrinoni A, Ciani B, Candi E et al. The cornified envelope: a model of cell death in the skin. Results Probl Cell Differ 1998; 24: 175\u2013212.","journal-title":"Results Probl Cell Differ"},{"key":"BFcddis2016201_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrm1619","volume":"6","author":"E Candi","year":"2005","unstructured":"Candi E, Schmidt R, Melino G . The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328\u2013340.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcddis2016201_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1046\/j.1365-2133.1999.02810.x","volume":"140","author":"AD Irvine","year":"1999","unstructured":"Irvine AD, McLean WH . Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 1999; 140: 815\u2013828.","journal-title":"Br J Dermatol"},{"issue":"R2","key":"BFcddis2016201_CR6","doi-asserted-by":"publisher","first-page":"R189","DOI":"10.1093\/hmg\/ddr379","volume":"20","author":"WH McLean","year":"2011","unstructured":"McLean WH, Moore CB . Keratin disorders: from gene to therapy. Hum Mol Genet 2011; 20 (R2): R189\u2013R197.","journal-title":"Hum Mol Genet"},{"key":"BFcddis2016201_CR7","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1046\/j.1523-1747.2000.00983.x","volume":"114","author":"A Terrinoni","year":"2000","unstructured":"Terrinoni A, Puddu P, Didona B, De Laurenzi V, Candi E, Smith FJ et al. A mutation in the V1 domain of K16 is responsible for unilateral palmoplantar verrucous nevus. J Invest Dermatol 2000; 114: 1136\u20131140.","journal-title":"J Invest Dermatol"},{"key":"BFcddis2016201_CR8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/19539","volume":"398","author":"A Yang","year":"1999","unstructured":"Yang A . p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714\u2013718.","journal-title":"Nature"},{"key":"BFcddis2016201_CR9","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1007\/s00018-008-8119-x","volume":"65","author":"E Candi","year":"2008","unstructured":"Candi E, Cipollone R, Rivetti di Val Cervo P, Gonfloni S, Melino G, Knight R . p63 in epithelial development. Cell Mol Life Sci 2008; 65: 3126\u20133133.","journal-title":"Cell Mol Life Sci"},{"key":"BFcddis2016201_CR10","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/19531","volume":"398","author":"AA Mills","year":"1999","unstructured":"Mills AA . p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398: 708\u2013713.","journal-title":"Nature"},{"key":"BFcddis2016201_CR11","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng1744","volume":"38","author":"R Yi","year":"2006","unstructured":"Yi R . Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat Genet 2006; 38: 356\u2013362.","journal-title":"Nat Genet"},{"key":"BFcddis2016201_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1073\/pnas.0810766105","volume":"106","author":"R Yi","year":"2009","unstructured":"Yi R, Pasolli HA, Landthaler M, Hafner M, Ojo T, Sheridan R et al. DGCR8-dependent microRNA biogenesis is essential for skin development. Proc Natl Acad Sci USA 2009; 106: 498\u2013502.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2016201_CR13","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1038\/cddis.2012.174","volume":"3","author":"G Viticchie","year":"2012","unstructured":"Viticchie G, Lena AM, Cianfarani F, Odorisio T, Annicchiarico-Petruzzelli M, Melino G et al. MicroRNA-203 contributes to skin re-epithelialization. Cell Death Dis 2012; 3: e435.","journal-title":"Cell Death Dis"},{"key":"BFcddis2016201_CR14","first-page":"14","volume":"3","author":"GH Stein","year":"1998","unstructured":"Stein GH, Dulic V . Molecular mechanisms for the senescent cell cycle arrest. J Investig Dermatol Symp Proc 1998; 3: 14\u201318.","journal-title":"J Investig Dermatol Symp Proc"},{"key":"BFcddis2016201_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nri1689","volume":"5","author":"AM Bowcock","year":"2005","unstructured":"Bowcock AM, Krueger JG . Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 2005; 5: 699\u2013711.","journal-title":"Nat Rev Immunol"},{"key":"BFcddis2016201_CR16","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes MA, Bowcock AM, Krueger JG . Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866\u2013873.","journal-title":"Nature"},{"key":"BFcddis2016201_CR17","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1038\/cddis.2012.152","volume":"3","author":"A Terrinoni","year":"2012","unstructured":"Terrinoni A, Serra V, Codispoti A, Talamonti E, Bui L, Palombo R et al. Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis. Cell Death Dis 2012; 3: e416.","journal-title":"Cell Death Dis"},{"key":"BFcddis2016201_CR18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/497707","volume":"77","author":"AJ Cassidy","year":"2005","unstructured":"Cassidy AJ, van Steensel MA, Steijlen PM, van Geel M, van der Velden J, Morley SM et al. A homozygous missense mutation in TGM5 abolishes epidermal transglutaminase 5 activity and causes acral peeling skin syndrome. Am J Hum Genet 2005; 77: 909\u2013917.","journal-title":"Am J Hum Genet"},{"key":"BFcddis2016201_CR19","doi-asserted-by":"publisher","first-page":"13693","DOI":"10.1074\/jbc.273.22.13693","volume":"273","author":"E Candi","year":"1998","unstructured":"Candi E, Melino G, Lahm A, Ceci R, Rossi A, Kim IG et al. Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processing. J Biol Chem 1998; 273: 13693\u201313702.","journal-title":"J Biol Chem"},{"key":"BFcddis2016201_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/138920010791196328","volume":"11","author":"C Albanesi","year":"2010","unstructured":"Albanesi C, Pastore S . Pathobiology of chronic inflammatory skin diseases: interplay between keratinocytes and immune cells as a target for anti-inflammatory drugs. Curr Drug Metab 2010; 11: 210\u2013227.","journal-title":"Curr Drug Metab"},{"key":"BFcddis2016201_CR21","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1038\/cddis.2012.69","volume":"3","author":"S Madonna","year":"2012","unstructured":"Madonna S, Scarponi C, Pallotta S, Cavani A, Albanesi C . Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis. Cell Death Dis 2012; 3: e334.","journal-title":"Cell Death Dis"},{"key":"BFcddis2016201_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/ars.2007.1716","volume":"10","author":"I Dalle-Donne","year":"2008","unstructured":"Dalle-Donne I, Milzani A, Gagliano N, Colombo R, Giustarini D, Rossi R . Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal 2008; 10: 445\u2013473.","journal-title":"Antioxid Redox Signal"},{"key":"BFcddis2016201_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12033-009-9189-1","volume":"43","author":"JT Hancock","year":"2009","unstructured":"Hancock JT . The role of redox mechanisms in cell signalling. Mol Biotechnol 2009; 43: 162\u2013166.","journal-title":"Mol Biotechnol"},{"key":"BFcddis2016201_CR24","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/bjd.12144","volume":"168","author":"T Bacchetti","year":"2013","unstructured":"Bacchetti T, Campanati A, Ferretti G, Simonetti O, Liberati G, Offidani AM . Oxidative stress and psoriasis: the effect of antitumour necrosis factor-alpha inhibitor treatment. Br J Dermatol 2013; 168: 984\u2013989.","journal-title":"Br J Dermatol"},{"key":"BFcddis2016201_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/138955709787001712","volume":"9","author":"M Lopez-Lazaro","year":"2009","unstructured":"Lopez-Lazaro M . Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 2009; 9: 31\u201359.","journal-title":"Mini Rev Med Chem"},{"key":"BFcddis2016201_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.mrfmmm.2004.01.015","volume":"551","author":"KA O'Leary","year":"2004","unstructured":"O'Leary KA, de Pascual-Teresa S, Needs PW, Bao YP, O'Brien NM, Williamson G . Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res 2004; 551: 245\u2013254.","journal-title":"Mutat Res"},{"key":"BFcddis2016201_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0304-3835(03)00386-0","volume":"199","author":"K Sakata","year":"2003","unstructured":"Sakata K, Hirose Y, Qiao Z, Tanaka T, Mori H . Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line. Cancer Lett 2003; 199: 139\u2013145.","journal-title":"Cancer Lett"},{"key":"BFcddis2016201_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1023\/A:1021624520740","volume":"243","author":"SY Cho","year":"2003","unstructured":"Cho SY, Park SJ, Kwon MJ, Jeong TS, Bok SH, Choi WY et al. Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem 2003; 243: 153\u2013160.","journal-title":"Mol Cell Biochem"},{"key":"BFcddis2016201_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.nutr.22.111401.144957","volume":"22","author":"JA Ross","year":"2002","unstructured":"Ross JA, Kasum CM . Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002; 22: 19\u201334.","journal-title":"Annu Rev Nutr"},{"key":"BFcddis2016201_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","volume":"79","author":"C Manach","year":"2004","unstructured":"Manach C, Scalbert A, Morand C, Remesy C, Jimenez L . Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79: 727\u2013747.","journal-title":"Am J Clin Nutr"},{"key":"BFcddis2016201_CR31","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1089\/ars.2012.4581","volume":"18","author":"D Del Rio","year":"2013","unstructured":"Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A . Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 2013; 18: 1818\u20131892.","journal-title":"Antioxid Redox Signal"},{"key":"BFcddis2016201_CR32","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol 2009; 182: 5836\u20135845.","journal-title":"J Immunol"},{"key":"BFcddis2016201_CR33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/carcin\/10.4.777","volume":"10","author":"H Hennings","year":"1989","unstructured":"Hennings H, Kruszewski FH, Yuspa SH, Tucker RW . Intracellular calcium alterations in response to increased external calcium in normal and neoplastic keratinocytes. Carcinogenesis 1989; 10: 777\u2013780.","journal-title":"Carcinogenesis"},{"key":"BFcddis2016201_CR34","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1083\/jcb.109.3.1207","volume":"109","author":"SH Yuspa","year":"1989","unstructured":"Yuspa SH, Kilkenny AE, Steinert PM, Roop DR . Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol 1989; 109: 1207\u20131217.","journal-title":"J Cell Biol"},{"key":"BFcddis2016201_CR35","doi-asserted-by":"publisher","first-page":"10270","DOI":"10.1073\/pnas.90.21.10270","volume":"90","author":"JM Carroll","year":"1993","unstructured":"Carroll JM, Albers KM, Garlick JA, Harrington R, Taichman LB . Tissue- and stratum-specific expression of the human involucrin promoter in transgenic mice. Proc Natl Acad Sci USA 1993; 90: 10270\u201310274.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2016201_CR36","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1074\/mcp.M700334-MCP200","volume":"7","author":"AA Raymond","year":"2008","unstructured":"Raymond AA, Gonzalez de Peredo A, Stella A, Ishida-Yamamoto A, Bouyssie D, Serre G et al. Lamellar bodies of human epidermis: proteomics characterization by high throughput mass spectrometry and possible involvement of CLIP-170 in their trafficking\/secretion. Mol Cell Proteomics 2008; 7: 2151\u20132175.","journal-title":"Mol Cell Proteomics"},{"key":"BFcddis2016201_CR37","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/j.0022-202X.2005.23934.x","volume":"125","author":"M Schmuth","year":"2005","unstructured":"Schmuth M, Ortegon AM, Mao-Qiang M, Elias PM, Feingold KR, Stahl A . Differential expression of fatty acid transport proteins in epidermis and skin appendages. J Invest Dermatol 2005; 125: 1174\u20131181.","journal-title":"J Invest Dermatol"},{"key":"BFcddis2016201_CR38","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0022-2275(20)38476-5","volume":"29","author":"M Ponec","year":"1988","unstructured":"Ponec M, Weerheim A, Kempenaar J, Mommaas AM, Nugteren DH . Lipid composition of cultured human keratinocytes in relation to their differentiation. J Lipid Res 1988; 29: 949\u2013961.","journal-title":"J Lipid Res"},{"key":"BFcddis2016201_CR39","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1096\/fj.10-172288","volume":"25","author":"R Sestito","year":"2011","unstructured":"Sestito R, Madonna S, Scarponi C, Cianfarani F, Failla CM, Cavani A et al. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J 2011; 25: 916\u2013927.","journal-title":"FASEB J"},{"key":"BFcddis2016201_CR40","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4049\/jimmunol.1102224","volume":"188","author":"AB Van Belle","year":"2012","unstructured":"Van Belle AB, de Heusch M, Lemaire MM, Hendrickx E, Warnier G, Dunussi-Joannopoulos K et al. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J Immunol 2012; 188: 462\u2013469.","journal-title":"J Immunol"},{"key":"BFcddis2016201_CR41","doi-asserted-by":"publisher","first-page":"33676","DOI":"10.1074\/jbc.M204204200","volume":"277","author":"D Lejeune","year":"2002","unstructured":"Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC . Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 2002; 277: 33676\u201333682.","journal-title":"J Biol Chem"},{"key":"BFcddis2016201_CR42","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/stem.1609","volume":"32","author":"G Huang","year":"2014","unstructured":"Huang G, Yan H, Ye S, Tong C, Ying QL . STAT3 phosphorylation at tyrosine 705 and serine 727 differentially regulates mouse ESC fates. Stem Cells 2014; 32: 1149\u20131160.","journal-title":"Stem Cells"},{"key":"BFcddis2016201_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1105166","volume":"307","author":"ZL Yuan","year":"2005","unstructured":"Yuan ZL, Guan YJ, Chatterjee D, Chin YE . Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 2005; 307: 269\u2013273.","journal-title":"Science"},{"key":"BFcddis2016201_CR44","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ncb1857","volume":"11","author":"Y Nie","year":"2009","unstructured":"Nie Y, Erion DM, Yuan Z, Dietrich M, Shulman GI, Horvath TL et al. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol 2009; 11: 492\u2013500.","journal-title":"Nat Cell Biol"},{"key":"BFcddis2016201_CR45","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445: 648\u2013651.","journal-title":"Nature"},{"key":"BFcddis2016201_CR46","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R . STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9: 798\u2013809.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2016201_CR47","first-page":"282","volume":"95","author":"MA Feely","year":"2015","unstructured":"Feely MA, Smith BL, Weinberg JM . Novel psoriasis therapies and patient outcomes, part 2: biologic treatments. Cutis 2015; 95: 282\u2013290.","journal-title":"Cutis"},{"key":"BFcddis2016201_CR48","first-page":"164","volume":"95","author":"MA Feely","year":"2015","unstructured":"Feely MA, Smith BL, Weinberg JM . Novel psoriasis therapies and patient outcomes, part 1: topical medications. Cutis 2015; 95: 164\u2013168 170.","journal-title":"Cutis"},{"key":"BFcddis2016201_CR49","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1038\/jid.2014.81","volume":"134","author":"A Johnston","year":"2014","unstructured":"Johnston A, Gudjonsson JE . 22 again: IL-22 as a risk gene and important mediator in psoriasis. J Invest Dermatol 2014; 134: 1501\u20131503.","journal-title":"J Invest Dermatol"},{"key":"BFcddis2016201_CR50","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/jid.2014.5","volume":"134","author":"P Nikamo","year":"2014","unstructured":"Nikamo P, Cheuk S, Lysell J, Enerback C, Bergh K, Xu Landen N et al. Genetic variants of the IL22 promoter associate to onset of psoriasis before puberty and increased IL-22 production in T cells. J Invest Dermatol 2014; 134: 1535\u20131541.","journal-title":"J Invest Dermatol"},{"key":"BFcddis2016201_CR51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/jid.2010.255","volume":"131","author":"K Miyoshi","year":"2011","unstructured":"Miyoshi K, Takaishi M, Nakajima K, Ikeda M, Kanda T, Tarutani M et al. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol 2011; 131: 108\u2013117.","journal-title":"J Invest Dermatol"},{"key":"BFcddis2016201_CR52","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1055\/s-0030-1270762","volume":"77","author":"M Hamalainen","year":"2011","unstructured":"Hamalainen M, Nieminen R, Asmawi MZ, Vuorela P, Vapaatalo H, Moilanen E . Effects of flavonoids on prostaglandin E2 production and on COX-2 and mPGES-1 expressions in activated macrophages. Planta Med 2011; 77: 1504\u20131511.","journal-title":"Planta Med"},{"key":"BFcddis2016201_CR53","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1248\/bpb.32.1500","volume":"32","author":"M Jin","year":"2009","unstructured":"Jin M, Yang JH, Lee E, Lu Y, Kwon S, Son KH et al. Antiasthmatic activity of luteolin-7-O-glucoside from Ailanthus altissima through the downregulation of T helper 2 cytokine expression and inhibition of prostaglandin E2 production in an ovalbumin-induced asthma model. Biol Pharmaceut Bull 2009; 32: 1500\u20131503.","journal-title":"Biol Pharmaceut Bull"},{"key":"BFcddis2016201_CR54","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jep.2012.04.001","volume":"141","author":"I Suntar","year":"2012","unstructured":"Suntar I, Kupeli Akkol E, Keles H, Yesilada E, Sarker SD, Arroo R et al. Efficacy of Daphne oleoides subsp. kurdica used for wound healing: identification of active compounds through bioassay guided isolation technique. J Ethnopharmacol 2012; 141: 1058\u20131070.","journal-title":"J Ethnopharmacol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2016201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016201","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T09:04:33Z","timestamp":1672823073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2016201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,18]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8]]}},"alternative-id":["BFcddis2016201"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2016.201","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,18]]},"assertion":[{"value":"12 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}